Integrated purification and measurement of DNA methylation and co-measurement of mutations and/or mRNA expression levels in an automated reaction cartridge

Inventors

Lai, Edwin Wei-Lung • Kohlway, Andrew • Van Atta, Reuel • Higuchi, Russell • Gall, Alexander A. • KOCMOND, KRISZTEN

Assignees

Cepheid

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-12539510-B2

Patent

Publication Date

2026-02-03

Expiration Date


Abstract

Methods of determining methylation of DNA are provided that include filtering a biological sample comprising a nucleic acid with a first matrix material to purify the DNA; eluting and denaturing the DNA to produce eluted denatured DNA; heating the DNA in the presence of bisulfite ions to produce deaminated nucleic acid; optionally contacting said deaminated nucleic acid with a second matrix material; desulphonating and eluting the bound deaminated nucleic acid; and performing methylation specific PCR, nucleic acid sequencing, and/or high resolution melting analysis (HRM) on said bisulfite-converted nucleic acid to determine the methylation of said nucleic acid, wherein multiple steps may be performed in a single reaction cartridge.

Core Innovation

The automated microfluidic cartridge determines a methylation state of a nucleic acid. It comprises a sample receiving chamber, a first column comprising a first matrix material, an optional second column with a second matrix material, chambers configured to contain reagents and buffers including a bisulfite reagent and a desulphonation/elution buffer, and a temperature-controlled reaction channel or chamber. Microfluidic channels and valves selectively place the cartridge components in fluid communication around a central valve configured to accommodate a plunger for fluid transfer.

The cartridge is configured to perform bisulfite conversion in the reaction channel or chamber, which can be subjected to thermocycling and subsequent PCR amplification of converted nucleic acid. The system supports extraction, washing, desulphonation, optional co-purification of RNA and DNA, and methylation assays including methylation-specific PCR, MethyLight, sequencing, and high-resolution melting. Background sections are omitted, so the problem being solved is not explicitly described in patent.

Claims Coverage

The claims identify one independent claim covering a microfluidic cartridge for determining a nucleic acid methylation state, comprising four main inventive features.

Cartridge components and temperature-controlled reaction chamber

The cartridge comprises a sample receiving chamber, a first column comprising a first matrix material, an optional second column comprising a second matrix material, a temperature-controlled reaction channel or chamber, and chambers configured to contain reagents and buffers, including a bisulfite reagent and a desulphonation/elution buffer.

Selective microfluidic fluid communication

The sample receiving chamber, columns, reagent and buffer chambers, and temperature-controlled reaction channel or chamber are selectively placed in fluid communication by microfluidic channels and valves.

Central valve and plunger arrangement

The cartridge components are disposed around a central valve and selectively in fluid communication with a channel in the central valve, which is configured to accommodate a plunger capable of drawing fluid into or out of a chamber in fluid communication with the central valve.

Bisulfite conversion and PCR amplification

The cartridge is configured to perform bisulfite conversion in the reaction channel or chamber, which is configured for thermocycling and subsequent amplification of converted nucleic acid by polymerase chain reaction.

The independent claim covers the structural arrangement of cartridge chambers and columns disposed around a central valve and plunger, selective microfluidic fluid communication, and a temperature-controlled reaction chamber configured for bisulfite conversion and subsequent PCR amplification.

Stated Advantages

The disclosed benefits include reduced processing time, reduced user variability, and reduced sample loss.

One comparison reports methylation-analysis results comparable to commercial tube-based methods with substantially less labor time, specifically reporting a workflow labor time of about 5 minutes for the cartridge workflow compared with 2 to 3 hours for comparison methods.

Documented Applications

Determining the methylation state of nucleic acids, including cancer-associated targets such as MGMT, BNC1, ADAMTS1, BRCA1, AKR1B1, RASSF1A, HOXB4, HIST1H3C, TM6SF1, and RASGRF2 in pancreatic cancer cell lines as well as plasma, cell-line, and urine samples.

Performing methylation assays including methylation-specific PCR, MethyLight, nested or multiplex PCR, quantitative PCR, DNA sequencing, and high-resolution melting analysis.

Nucleic-acid extraction, washing, and desulphonation, with optional co-purification and co-measurement of RNA and DNA expression or mutations.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.